Page 11 of the annual report indicates that Avita filed for uplisting of the ADR shares to the Nasdaq, so we should be hearing about the response on that fairly soon either way.
"On July 19, 2019, AVITA confidentially submitted a draft registration statement on Form 20-F under the Securities Exchange Actof 1934 with the Securities and Exchange Commission relating to the proposed registration in the United States of its class ofAmerican Depositary Shares representing ordinary shares of the Company. This disclosure does not constitute an offer to sell,or the solicitation of an offer to buy, any securities of the Company. In connection with the registration of such class of securities,on 2 August 2019, the Company applied for listing on NASDAQ. There is no guarantee the Company’s efforts will be successfuland that the Company may abandon its efforts to register the class of shares and the NASDAQ application at any time at its sole discretion."
- Forums
- ASX - By Stock
- Ann: Appendix 4E and Preliminary Final Report
AVH
avita medical inc.
Add to My Watchlist
1.82%
!
$1.68

Page 11 of the annual report indicates that Avita filed for...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.68 |
Change
0.030(1.82%) |
Mkt cap ! $116.4M |
Open | High | Low | Value | Volume |
$1.70 | $1.73 | $1.67 | $304.8K | 179.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 6148 | $1.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 873 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 14230 | 1.670 |
5 | 9633 | 1.665 |
2 | 6800 | 1.660 |
5 | 29483 | 1.650 |
2 | 13487 | 1.645 |
Price($) | Vol. | No. |
---|---|---|
1.680 | 873 | 2 |
1.685 | 1197 | 1 |
1.690 | 5523 | 1 |
1.695 | 4767 | 3 |
1.705 | 5860 | 2 |
Last trade - 11.40am 04/07/2025 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online